Fintech World Post: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Fintech World Post.

Press releases published on April 21, 2026

PCBB Appoints Matt Wallace as EVP & Chief Information Officer
DOL and IRS Enforcement Intensifies: Why Employee Benefit Plan Audit Quality Is Now a Fiduciary Risk
Exail Technologies to Present at the AI & Tech Virtual Investor Conference April 23rd
UPST Investors Have Opportunity to Lead Upstart Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Revolution Medicines to Present Pivotal Phase 3 RASolute 302 Clinical Trial Results for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer During a Plenary Session at the 2026 ASCO Annual Meeting
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Bioxtreme Announces Strategic Investment Led by Serra Holding and Introduces Plaxtreme to Accelerate Neurorehabilitation Innovation
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—GSAT, GRTX, WBS, and FORA
Record-Breaking SpringFest 2026 Affirms A4M as the Central Forum for Longevity Medicine
QuestionPro Acquires Fathom to Lead in AI-Powered Open-Ended Analysis
Northeast Bank Announces Dates for Fiscal 2026 Third Quarter Earnings Results and Conference Call
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—LEG, AVNS, TALK, and MKC
Alexander’s Announces First Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
TradeView Releases New Guide on Platform Utility and Market Position
Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting
Physical AI Market Set to Hit $15.24 Billion by 2032: Future Growth & Industry Trends
SMCI Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Fintech World Post

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.